ArticleFrontiers in medicine2025
Case Report: Rare pleural effusion-a case of B-lymphoblastic lymphoma presenting with pleural effusion and diagnostic challenges.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lymphoblastic lymphoma is a rare type of malignant lymphoma. B-lymphoblastic lymphoma with pleural effusion as the initial manifestation is extremely rare; in this study, we report a specific and challenging diagnostic process. Case presentation: We present the case of a 67-year-old woman who was initially diagnosed with tuberculous pleurisy with a right pleural effusion. The pleural effusion was an exudate composed primarily of mononuclear cells with elevated adenosine deaminase (ADA) and lactate dehydrogenase (LDH). The cytological results of the pleural effusion were negative. The contrast-enhanced CT suggested right pleural nodules with partial pleural thickening. Subsequently, a CT-guided percutaneous needle pleural biopsy was performed, and pathological consultation, bone marrow biopsy, and flow cytology examination were carried out. Finally, B-lymphoblastic lymphoma was diagnosed. During a recent follow-up, the patient showed signs of improvement nearly without pleural effusion after chemotherapy. Conclusion: Malignant pleural effusion caused by lymphoma can be easily misdiagnosed as tuberculous pleurisy, as both conditions commonly show markedly elevated levels of ADA and LDH. Flow cytology examination of pleural fluid can be considered, and histological specimens should be actively obtained to clarify the pathological diagnosis. For patients with extensive pleural thickening, a CT-guided percutaneous pleural biopsy can be preferentially selected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.